Four notes:
1. Net loss in the first quarter was $22.9 million, a 10.5 percent greater loss than the prior year.
2. Alphatec expects total revenue for the 2021 fiscal year to be about $190 million, representing an approximate revenue growth of 33 percent compared to 2020.
3. “Market-shaping innovation, integrated with unprecedented intraoperative information, is compelling an increasing number of surgeons and exclusive distributors to partner with [Alphatec],” Chair and CEO Pat Miles said in a May 6 news release.
4. Projected growth will be driven by launches of procedures and products and the rejuvenation of Alphatec’s distribution network, the company said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
